Fintel on MSN9h
Morgan Stanley Downgrades Third Harmonic Bio (THRD)
Fintel reports that on February 12, 2025, Morgan Stanley downgraded their outlook for Third Harmonic Bio (NasdaqGM:THRD) from ...
Fintel on MSN21h
Raymond James Downgrades Third Harmonic Bio (THRD)
Fintel reports that on February 11, 2025, Raymond James downgraded their outlook for Third Harmonic Bio (NasdaqGM:THRD) from ...
The Pharma Letter9h
Third Harmonic and Inventiva slash workforces
American biotech Third Harmonic Bio and Inventiva have announced plans to reduce their respective workforces by 50% as part of cost-cutting measures. Both companies are shifting their focus to a ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (EW), Arrowhead Pharmaceuticals (ARWR) and Exelixis (EXEL)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edwards Lifesciences (EW – Research Report), Arrowhead ...
Oppenheimer Reaffirms Their Buy Rating on Blueprint Medicines (BPMC)
Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Blueprint Medicines (BPMC – Research Report) yesterday and set a price target of ...
North American Morning Briefing: Stock Futures -2-
Anavex Life Sciences Corp (AVXL) is expected to report $-0.17 for 1Q. BankFinancial Corp (BFIN) is expected to report $0.20 for 4Q. Barrick Gold Corp (ABX.T,GOLD) is expected to report $0.63 for 4Q.